|
|
|
| Fibromyalgia syndrome after comprehensive treatment of breast cancer: a case report |
| DING Xia1, LI Yan1, CUI Yiyi1, SHEN Yingying2, GU Jianzhong2, GUO Yong2 |
1. First Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou 310053, China;
2. Department of Oncology, First Affiliated Hospital, Zhejiang Chinese Medical University, Hangzhou 310006, China |
|
|
|
Abstract Fibromyalgia syndrome after comprehensive treatment of breast cancer is rare and seldom reported. Here we present a case of a 50-year-old female patient,who was admitted to the hospital because of generalized fibromyalgia for 3 months and brain metastasis after the right breast carcinoma surgery for 1 month, and the clinical diagnosis was brain metastasis from breast carcinoma combined with fibromyalgia syndrome. The fibromyalgia were relieved with proper symptomatic treatment but the patient eventually died of tumor progression.
|
|
Received: 08 January 2016
|
|
|
乳腺癌综合治疗后合并纤维肌痛综合征一例
乳腺癌综合治疗后合并纤维肌痛综合征临床非常罕见。本文报道一例50岁女性患者，因全身肌肉疼痛3个月余、发现右乳癌术后脑转移1个月而入院，临床诊断为乳腺癌术后脑转移合并纤维肌痛综合征。针对纤维肌痛综合征治疗后症状缓解。患者最终死于肿瘤进展。
关键词：
乳腺肿瘤/并发症,
纤维肌痛/病因学,
综合征,
病例报告
|
|
| [[1]] |
WOLFE F, SMYTHE H A, YUNUS M B, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia[J]. Arthritis Rheum,1990, 33(2):160-172.
|
|
|
| [[2]] |
WOLFE F, ROSS K, ANDERSON J, et al. The prevalence and characteristics of fibromyalgia in the general population[J]. Arthritis Rheum, 1995, 38(1):19-28.
|
|
|
| [[3]] |
AMEL-KASHIPAZ M R, SWINDEN D, TODD I, et al. Normal production of inflammatory cytokines in chronic fatigue and fibromyalgia syndromes determined by intracellular cytokine staining in short-term cultured blood mononuclear cells[J]. Clin Exp Immunol, 2003, 132(2):360-365.
|
|
|
| [[4]] |
郁兰芳.氨基酸和核苷类代谢产物对乳腺癌疗效预测价值的研究[D].杭州:浙江大学,2008. YU Lanfang. Study of the predictive value of amino acids and nucleosides metabolites in breast cancer[D]. Hangzhou: Zhejiang University, 2008.(in Chinese)
|
|
|
| [[5]] |
陈小平.乳腺癌患者血清P物质表达的临床意义[J].中华医师进修杂志,2013,36(11):1-3. CHEN Xiaoping. Clinical significance of serum substance P in the patients with breast cancer[J]. Chinese Journal of Postgraduates Medicine, 2013, 36(11):1-3.(in Chinese)
|
|
|
| [[6]] |
周云丽,付正,李金萍,等.P物质及其受体在乳腺癌中的表达和临床意义[J].中华微生物学和免疫学杂志,2014,34(11):874-880. ZHOU Yunli, FU Zheng, LI Jinping, et al. Expression of SP and neurokinin-1 receptor in patients with breast cancer and their correlations with clinicopathological features[J]. Chinese Journal Microbiology and Immunology, 2014, 34(11):874-880.(in Chinese)
|
|
|
| [[7]] |
HENRY J L. Future basic science directions into mechanisms of neuropathic pain[J]. J Orofac Pain, 2004, 18(4):306-310.
|
|
|
| [[8]] |
王凌,李丽,司军强.P物质与疼痛的关系[J].包头医学院学报,2009,25(5):102-104. WANG Ling, LI li, SI Junqiang. The correlation between substance P and pains[J]. Journal of Baotou Medical College, 2009, 25(5):102-104.(in Chinese)
|
|
|
| [[9]] |
刘连科,刘嘉玲.肿瘤相关风湿综合征[J]. 中国临床医生,2006,34(3):2-4. LIU Lianke, LIU Jialing. Tumor related rheumatism syndrome[J]. Chinese Journal for Clinicians, 2006, 34(3):2-4. (in Chinese)
|
|
|
| [[10]] |
葛均波, 徐永健.内科学[M].8版. 北京:人民卫生出版社,2013:866-867. GE Junbo, XU Yongjian. Internal medicine[M]. 8th ed. Beijing: People's Medical Publishing House Co.Ltd, 2013:866-867.(in Chinese)
|
|
|
| [[11]] |
GOLDENBERG D L, BURCKHARDT C, CROFFORD L. Management of fibromyalgia syndrome[J]. JAMA, 2004, 292(19):2388-2395.
|
|
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
| |
Shared |
|
|
|
|
| |
Discussed |
|
|
|
|
